Back to top

Image: Bigstock

Here's What Key Metrics Tell Us About Community Health Systems (CYH) Q3 Earnings

Read MoreHide Full Article

Community Health Systems (CYH - Free Report) reported $2.76 billion in revenue for the quarter ended September 2026, representing a year-over-year decline of 10.7%. EPS of -$0.48 for the same period compares to $1.27 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $2.78 billion, representing a surprise of -0.89%. The company delivered an EPS surprise of -118.18%, with the consensus EPS estimate being -$0.22.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Community Health Systems performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
  • Adjusted admissions: 195,677 compared to the 191,673 average estimate based on two analysts.
  • Patient days: 360,711.00 Days versus the two-analyst average estimate of 369,644.70 Days.
  • Beds in Service: 7,674 compared to the 7,070 average estimate based on two analysts.
  • Same-store occupancy rate (average beds in service): 51.1% versus the two-analyst average estimate of 56.8%.
  • Number of Hospitals: 60 versus the two-analyst average estimate of 60.
  • Admissions: 85,591 compared to the 84,410 average estimate based on two analysts.
  • Licensed Beds: 8,872 versus 8,863 estimated by two analysts on average.

View all Key Company Metrics for Community Health Systems here>>>

Shares of Community Health Systems have returned -2.4% over the past month versus the Zacks S&P 500 composite's -0.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Published in